Benchmark Upgrades OncoCyte Corp (OCX) to Buy

January 7, 2021 4:41 AM EST
Get Alerts OCX Hot Sheet
Price: $3.20 --0%

Rating Summary:
    4 Buy, 5 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE

Benchmark analyst Bruce Jackson upgraded OncoCyte Corp (NYSE: OCX) from Speculative Buy to Buy with a price target of $6.00.


For an analyst ratings summary and ratings history on OncoCyte Corp click here. For more ratings news on OncoCyte Corp click here.


Shares of OncoCyte Corp closed at $2.60 yesterday.


You May Also Be Interested In





Related Categories

Upgrades